Using patient information to predict hospital readmissions for COPD
Integrative Informatics Approach to Predict Readmissions and Improve Outcomes in COPD
This study is looking to help people with Chronic Obstructive Pulmonary Disease (COPD) by finding out which patients are at risk of going back to the hospital after they leave, so they can get better support at home based on their health and social needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Buffalo NIH-funded |
| Lab location | 1 site (Amherst, United States) |
| Project ID | NIH-11059174 on NIH RePORTER |
What this research studies
This research focuses on improving the care of patients with Chronic Obstructive Pulmonary Disease (COPD) by developing predictive models that incorporate both clinical and social information. The goal is to identify high-risk patients who are likely to be readmitted to the hospital after discharge. By conducting interviews with patients, caregivers, and clinicians, the research aims to understand the social factors that contribute to readmissions. This information will be used to tailor care management interventions to better support these patients during their transition from hospital to home.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with Chronic Obstructive Pulmonary Disease who have recently been hospitalized and are at risk of readmission.
Not a fit: Patients with stable COPD who have not been hospitalized recently may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce hospital readmissions for COPD patients, leading to better health outcomes and improved quality of life.
How similar studies have performed: Other research has shown promise in using social determinants of health to improve patient outcomes, indicating that this approach could be effective.
Where this research is happening
Amherst, United States
- State University of New York at Buffalo — Amherst, United States (Active)
Researchers
- Principal investigator: Jacobs, David — State University of New York at Buffalo
- Study coordinator: Jacobs, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.